Goldman Sachs Downgrades Aetna (AET) to Sell
Tweet Send to a FriendGet Alerts AET Hot Sheet
Price: $60.04 +0.86%
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade AET Now!
Goldman Sachs downgraded Aetna (NYSE: AET) from Neutral to Sell with a price target of $45 (down from $50).
The firm said "we now see somewhat greater near-term downside risk to commercial margins following 1Q result."
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $43.05 yesterday, with a 52 week range of $33.43-$51.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm said "we now see somewhat greater near-term downside risk to commercial margins following 1Q result."
For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.
Shares of Aetna closed at $43.05 yesterday, with a 52 week range of $33.43-$51.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- William Blair Downgrades Savient Pharmaceuticals (SVNT) to Market Perform
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Goldman Sachs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
